Summary of Changes for February 2017

This page contains information on changes to the MBS that occurred during February 2017.

Page last updated: 25 November 2020

Summary of Item Changes

New item

Amended description

Germline BRCA gene mutation tests (Item 73295)
Patients who are found to have a BRCA1 or BRCA2 mutation should be referred for post-test genetic counselling, as there may be implications for other family members. Appropriate genetic counselling should be provided to the patient either by the specialist treating practitioner, a genetic counselling service or a clinical geneticist on referral.